Topics

Hologic Announces Financial Results for Second Quarter of Fiscal 2019

16:02 EDT 1 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
– Revenue of $818.4 Million Grows 3.7%, 5.2% in Constant Currency – – Company Posts GAAP Loss per Share of ($1.01) Due to Non-Cash Charges, Non-GAAP Diluted Earnings per Share (EPS) of $0.58 – – Compa...

Other Sources for this Article

Michael Watts
Vice President, Investor Relations and Corporate Communications
858-410-8588
Michael.watts@hologic.com

NEXT ARTICLE

More From BioPortfolio on "Hologic Announces Financial Results for Second Quarter of Fiscal 2019"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...